| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 14.80▼ | 14.75▼ | 14.73▼ | 15.39▼ | 13.66▲ |
| MA10 | 14.86▼ | 14.73▼ | 14.99▼ | 14.99▼ | 11.75▲ |
| MA20 | 14.84▼ | 15.02▼ | 15.28▼ | 13.90▲ | 7.41▲ |
| MA50 | 14.74▼ | 15.34▼ | 15.26▼ | 10.76▲ | 3.92▲ |
| MA100 | 14.97▼ | 15.17▼ | 14.39▲ | 6.82▲ | 3.15▲ |
| MA200 | 15.26▼ | 14.25▲ | 13.10▲ | 4.23▲ | 3.61▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.024▼ | -0.012▼ | -0.102▼ | -0.078▼ | 0.850▲ |
| RSI | 38.688▼ | 39.887▼ | 41.243▼ | 64.045▲ | 87.414▲ |
| STOCH | 20.590 | 47.218 | 28.852 | 77.650 | 92.984▲ |
| WILL %R | -100.000▼ | -68.953 | -70.139 | -46.738 | -13.240▲ |
| CCI | -283.715▼ | -41.518 | -81.267 | 26.056 | 104.527▲ |
|
Thursday, March 12, 2026 09:00 AM
Encouraging early clinical activity observed during ERAS-0015 dose escalation, including ongoing responses across multiple RAS-mutant tumors with favorable safety, tolerability, and pharmacokinetics ...
|
|
Tuesday, March 10, 2026 10:44 PM
Worldwide rights position Erasca to advance ERAS-0015 through a unified global development strategyERAS-0015’s promising early clinical data ...
|
|
Thursday, March 05, 2026 04:34 AM
ERAS-0015, a pan-RAS molecular glue, will be evaluated in combination with PRMT5 inhibitor vopimetostat Tango will sponsor the clinical trial and Erasca will supply ERAS-0015 at no cost SAN DIEGO, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/03/26 | 15.41 | 15.555 | 14.20 | 14.65 | 6,964,362 |
| 11/03/26 | 15.40 | 15.77 | 15.23 | 15.50 | 4,767,162 |
| 10/03/26 | 15.81 | 16.405 | 15.25 | 15.58 | 5,010,245 |
| 09/03/26 | 15.60 | 15.89 | 14.96 | 15.76 | 4,157,474 |
| 06/03/26 | 15.54 | 15.97 | 14.9701 | 15.47 | 4,972,553 |
| 05/03/26 | 14.74 | 15.665 | 14.74 | 15.54 | 5,849,993 |
| 04/03/26 | 14.31 | 15.27 | 14.18 | 15.12 | 4,858,291 |
| 03/03/26 | 14.22 | 14.60 | 13.84 | 14.10 | 2,693,547 |
| 02/03/26 | 13.26 | 14.625 | 13.26 | 14.53 | 3,895,777 |
| 27/02/26 | 13.54 | 13.78 | 13.21 | 13.66 | 5,951,361 |
|
|
||||
|
|
||||
|
|